Sysmex Corporation · TSE:6869
Sysmex — FY2007 3Q Earnings Presentation
10 slides from Sysmex's earnings presentation, Feb 5, 2008
Slide 1: FY2007 3Q Business Results
A Unique & Global Healthcare Testing Company FY2007 3Q Business Results February, 5 2008 SYSMEX CORPORATION
Slide 2: Topics - 1: Alliances
Outline of 3Q 2007 Results (ending in March 2008) Topics - 1 Alliances ¾ Alliance Formed with IDEXX; World’s Largest Animal Diagnostic Testing Company 9 IDEXX to place Sysmex products into its reference laboratories 9 The two companies to explore some ways to leverage their strengths >About IDEXX La
Slide 3: Topics - 2: New products/Technologies
Outline of 3Q 2007 Results (ending in March 2008) Topics - 2 New products/Technologies High sensitivity・Speedy・ ¾ Released HISCL-2000i, a fully automated immunoassay analyzer enabling highly Minimal sample volume sensitive and high-speed assay 9 Examine the presence or absence of infectious diseases
Slide 4: Financial Highlights
Outline of 3Q 2007 Results (ending in March 2008) Financial Highlights 90.0 14.0 (in billions of JPY) Exchange rate in the preceding 3Q report：1US$=¥116.2, 1EUR=¥148.0 80.0 78.3 Exchange rate in this 3Q report：1US$=¥117.3, 1EUR=¥162.8 12.0 70.7 (in billions of JPY) 70.0 10.4 As percentage of 62.9 9.
Slide 5: Geographic Segment Information (Americas & Europe)
Outline of 3Q 2007 Results (ending in March 2008) Geographic Segment Information (Americas & Europe) (in billions of JPY) 【 Americas 】 (Net Sales to (Operating ¾ Favorable trend in sales to blood centers Outside customers) Americas Income) 18 1.5 ¾ Extensive orders from integrated healthcare network
Slide 6: Geographic Segment Information (China & AP)
Outline of 3Q 2007 Results (ending in March 2008) Geographic Segment Information (China & AP) (in billions of JPY) 【China】 (Net Sales to (Operating ¾ Extensive orders for systems in the hematology segment Outside customers) China Income) ¾ Cost pressure due to reduction of test expenses (insurance p
Slide 7: Geographic Segment Information (Japan)
Outline of 3Q 2007 Results (ending in March 2008) Geographic Segment Information (Japan) 【Japan】 (in billions of JPY) ¾ Cost pressures from medical institutions whose management Japan faces harsh circumstances (Sales) (income) ¾ Accelerated reorganization of the industry including manufacturers, <In
Slide 8: FY2007 Consolidated Earnings Forecast
FY2007 Consolidated Earnings Forecast FY2007 Consolidated Earnings Forecast FY2007 Consolidated Earnings Forecast (Announced in May 2007) ¾ Sales: ¥112 billion ¾ Ordinary Income: ¥15.3 billion ¾ Income:¥ 9.8 billion ¾ Ordinary Income ratio: ¥13.7% ¾ Income ratio:8.8% Investment plan ¾ Equipment: ¥8.
Slide 9: Projected Dividend for FY2007
FY2007 Consolidated Earnings Forecast Projected Dividend for FY2007 Dividends Interim Year-end Total ratio dividend dividend (Consolidate) FY2007 ¥ ２０ ¥ ２０ ¥ ４０ ２０．８％ FY2006 ¥ １６ ¥ ２０ ¥ ３６ ２０．０％ (Announced in May 2007) 9
Slide 10: Forward-looking Statements / Challenging the Frontiers of Healthcare Testing
Forward-looking Statements This material contains forward-looking statements about Sysmex Corporation and its group companies (the Sysmex Group). These forward-looking statements are based on the current judgments and assumptions of the Sysmex Group in light of the information currently available to